Life Sciences: Biotech
Cells, not tools, may help fix arteries
Start-up gets $15m to test new method
In the past decade, artery repair has become one of the most lucrative industries in healthcare, spawning billion-dollar companies like Boston Scientific Corp. that make equipment to keep blood flowing smoothly through the body's most important vessels. (Full article: 850 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
